Result Summary for AZLF3002
| Protocol ID: | AZLF3002 |
| Clinical Study ID: | AZLF 3002 |
| Official Title: | Multicentre, open-label, pilot study to evaluate the efficacy and safety of a triple therapy combining AZT/3TC/ABC as a combined tablet of Trizivir, in HIV-infected patients with an undetectable viral load after quadruple therapy (COM, ABC, EFV) during CNAF 3008 study (La Francilienne). |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | abacavir/lamivudine/zidovudine |
| Trade/Product Name: | trizivir;trizivir |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: | Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.

Click
here to download result summary.